Aclarion Inc (ACON) - News Archive

In a notable development within the healthcare technology sector, Aclarion Inc. announced that its pioneering product, Nociscan, has been highlighted in the RSNA (Radiological Society of North America) edition of Siemen...

In the annals of contemporary medical enquiry, the understanding of Modic Changes (MC), as discerned through magnetic resonance imaging (MRI), has ascended to prominence, particularly as it is intricately linked to endp...

In the realm of contemporary medical innovation, Aclarion Inc. has recently unfolded a pivotal chapter within its ambitious LIFEHAB trial. The company has taken significant strides by successfully conducting its inaugur...

In the grand theatre of medical progress, where the eldritch shadows of affliction linger, a beacon of hope emerges with the advent of Aclarion Inc.’s strategic partnership with esteemed practitioner, Dr. Justin Kubeck,...

In a significant advancement within the field of surgical medicine, Aclarion Inc. has officially launched the Clinical Utility and Economic (CLUE) Trial. This innovative study aims to assess how frequently AI-generated...

In a significant leap for healthcare technology in Michigan, Aclarion, a company focused on advanced diagnostic solutions, has secured its first commercial agreement in the state to deploy its innovative Nociscan techno...

In a significant stride in the management of chronic low back pain, Aclarion Inc s Nociscan solution is set to play a critical role in the groundbreaking LIFEHAB trial. The trial, based in Norway, is a randomized contro...

Aclarion, Inc. Announces Pricing of Public Offering Amidst Financial ConcernsBROOMFIELD, CO Aclarion, Inc. (Nasdaq: ACON, ACONW), a healthcare technology company specializing in leveraging biomarkers and proprietary aug...

Aclarion, a leading medical technology company, has recently revealed its plans to launch the CLARITY trial, a pivotal multicenter, prospective, randomized study. This trial aims to further validate the superior surgica...

Aclarion Inc., a leading provider of surgical decision support technology, has recently forged a strategic partnership agreement with ATEC (Alpha Technology Company). The primary objective of this collaboration is to ex...

Aclarion Announces Reverse Stock Split to Enhance Value and Attract InvestorsBROOMFIELD, CO, Jan. 02, 2024 - Aclarion, Inc. (Nasdaq: ACON, ACONW), a leading healthcare technology company specializing in identifying the...